drugset / Trial / NCT01476098

A Study to Investigate the Effect of SB-705498 on Chronic Cough

NCT01476098

Phase 2 Completed 21 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to loook at the affect of oral SB-705498 on cough following an inhaled capsaicin challenge

Timeline

Start
2011-04
Primary completion
2011-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator SB-705498 Small molecule 400 mg Oral
Comparator SB-705498 Small molecule 600 mg Oral

Indications